ATC code H03
| ATC code H: Systemic hormonal preparations, excluding sex hormones and insulins |
|---|
|
| Other ATC codes |
ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H03A Thyroid preparations
[edit]H03AA Thyroid hormones
[edit]- H03AA01 Levothyroxine sodium
- H03AA02 Liothyronine sodium
- H03AA03 Combinations of levothyroxine and liothyronine
- H03AA04 Tiratricol
- H03AA05 Thyroid gland preparations
- H03AA51 Levothyroxine sodium and iodine compounds
H03B Antithyroid preparations
[edit]H03BA Thiouracils
[edit]- H03BA01 Methylthiouracil
- H03BA02 Propylthiouracil
- H03BA03 Benzylthiouracil
H03BB Sulphur-containing imidazole derivatives
[edit]- H03BB01 Carbimazole
- H03BB02 Thiamazole
- H03BB52 Thiamazole, combinations
H03BC Perchlorates
[edit]- H03BC01 Potassium perchlorate
H03BX Other antithyroid preparations
[edit]- H03BX01 Diiodotyrosine
- H03BX02 Dibromotyrosine
H03CA Iodine therapy
[edit]References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code H03". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QH03". WHO Collaborating Centre for Drug Statistics Methodology.